Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Ectodomain shedding of tumor necrosis factor receptor 1 (TNFR1) provides negative feedback to the inflammatory loop induced by TNFα. As the significance of this mechanism in obesity-associated pathologies is unclear, we aimed to unravel how much TNFR1 ectodomain shedding controls the development of nonalcoholic fatty liver disease (NAFLD), as well as its role in the development of insulin resistance. We used knockin mice expressing a mutated TNFR1 ectodomain (p55Δns), incapable of shedding and dampen the inflammatory response. Our data show that persistent TNFα signaling through this inability of TNFR1 ectodomain shedding contributes to chronic low-grade inflammation, which is confined to the liver. In spite of this, hepatic lipid levels were not affected by the nonshedding mutation in mice fed a chow diet, nor were they worse off following 12 weeks of high-fat diet (HFD) than controls (p55+/+) fed an HFD. We detected inflammatory infiltrates, hepatocellular necrosis, and apoptosis in livers of p55Δns/Δns mice fed an HFD, suggesting advanced progression of NAFLD toward nonalcoholic steatohepatitis (NASH). Indeed, fibrosis was present in p55Δns/Δns mice, but absent in wildtype mice, confirming that the p55Δns/Δns mice had a more severe NASH phenotype. Despite low-grade hepatic inflammation, insulin resistance was not observed in p55Δns/Δns mice fed a chow diet, and HFD-induced insulin resistance was no worse in p55Δns/Δns mice than p55+/+ mice. Conclusion: TNFR1 ectodomain shedding is not an essential feedback mechanism in preventing the development of hepatic steatosis or insulin resistance. It is, however, pivotal in attenuating the progression from “simple steatosis” towards a more serious phenotype with many NASH features. Targeting TNFR1 could therefore be beneficial in attenuating NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 1×
“and reversible state of NAFLD may, however, evolve into nonalcoholic steatohepatitis (NASH),(2) a condition of inflamed liver, which can further progress to liver fibrosis, cirrhosis, and ultimately hepatocellular carcinoma.(3) Although the mechanisms underlying the pathogenesis of NAFLD are not fully understood, both…”
BackgroundThe cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551 · cited 1×
“There is growing evidence connecting obesity and its associated pathologies, like NAFLD and insulin resistance, to the presence of a chronic low-grade inflammatory state.(36,37) We aimed to gain more insight into the biological significance of shedding of the TNFR1 ectodomain in these pathologies by studying the exten…”
BackgroundBeyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Tarrats, N., Moles, A., Morales, A., García-Ruiz, C., Fernández-Checa, J. C., & Marí, M. (2011) · Hepatology · doi:10.1002/hep.24388 · Cited by 128
Research works printed but not linked: 36
- Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome., HEPATOLOGY, 37, 917923, 10.1053/jhep.2003.50161 · DOI · Paper page
- Anderson, 2008, Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis., Pharmacol Rev, 60, 311357, 10.1124/pr.108.00001 · DOI · Paper page
- Tilg, 2000, Cytokines in alcoholic and nonalcoholic steatohepatitis., N Engl J Med, 343, 14671476, 10.1056/NEJM200011163432007 · DOI · Paper page
- Abiru, 2006, Serum cytokine and soluble cytokine receptor levels in patients with nonalcoholic steatohepatitis., Liver Int, 26, 3945, 10.1111/j.1478-3231.2005.01191.x · DOI · Paper page
- Crespo, 2001, Gene expression of tumor necrosis factor alpha and TNFreceptors, p55 and p75, in nonalcoholic steatohepatitis patients., HEPATOLOGY, 34, 11581163, 10.1053/jhep.2001.29628 · DOI · Paper page
- Endo, 2007, TNFalpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein1c (SREBP1c)., Exp Biol Med (Maywood), 232, 614621
- Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease., HEPATOLOGY, 37, 343350, 10.1053/jhep.2003.50048 · DOI · Paper page
- Memon, 2001, TNFalpha is not the cause of fatty liver disease in obese diabetic mice., Nat Med, 7, 23, 10.1038/83316 · DOI
- Dela, 2005, NFkappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis., Gastroenterology, 129, 16631674
- SchnyderCandrian, 2005, Hepatic steatosis in the absence of tumor necrosis factor in mice., Cytokine, 32, 287295, 10.1016/j.cyto.2005.11.004 · DOI
- Toda, 2010, Deletion of tumor necrosis factoralpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice., Biochim Biophys Acta, 1801, 655664
- Tomita, 2006, Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of nonalcoholic steatohepatitis in mice., Gut, 55, 415424, 10.1136/gut.2005.071118 · DOI · Paper page
- Uysal, 1997, Protection from obesityinduced insulin resistance in mice lacking TNFalpha function., Nature, 389, 610614, 10.1038/39335 · DOI · Paper page
- Pamir, 2009, Receptors for tumor necrosis factoralpha play a protective role against obesity and alter adipose tissue macrophage status., Endocrinology, 150, 41244134, 10.1210/en.2009-0137 · DOI · Paper page
- Romanatto, 2009, Deletion of tumor necrosis factoralpha receptor 1 (TNFR1) protects against dietinduced obesity by means of increased thermogenesis., J Biol Chem, 284, 3621336222, 10.1074/jbc.M109.030874 · DOI · Paper page
- Schreyer, 1998, Obesity and diabetes in TNFalpha receptordeficient mice., J Clin Invest, 102, 402411, 10.1172/JCI2849 · DOI · Paper page
- Hotamisligil, 1993, Adipose expression of tumor necrosis factoralpha: direct role in obesitylinked insulin resistance., Science, 259, 8791, 10.1126/science.7678183 · DOI · Paper page
- Ofei, 1996, Effects of an engineered human antiTNFalpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM., Diabetes, 45, 881885, 10.2337/diab.45.7.881 · DOI · Paper page
- Van Zee, 1992, Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo., Proc Natl Acad Sci U S A, 89, 48454849, 10.1073/pnas.89.11.4845 · DOI · Paper page
- Rowlands, 2011, Activation of TNFR1 ectodomain shedding by mitochondrial Ca2 determines the severity of inflammation in mouse lung microvessels., J Clin Invest, 121, 19861999, 10.1172/JCI43839 · DOI · Paper page
- Monroy, 2009, Impaired regulation of the TNFalpha converting enzymetissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans., Diabetologia, 52, 21692181, 10.1007/s00125-009-1451-3 · DOI
- Fiorentino, 2010, Increased tumor necrosis factor alphaconverting enzyme activity induces insulin resistance and hepatosteatosis in mice., HEPATOLOGY, 51, 103110, 10.1002/hep.23250 · DOI
- de Meijer, 2011, Tumor necrosis factor alphaconverting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice., PLoS ONE, 6, e25587, 10.1371/journal.pone.0025587 · DOI
- Serino, 2007, Mice heterozygous for tumor necrosis factoralpha converting enzyme are protected from obesityinduced insulin resistance and diabetes., Diabetes, 56, 25412546, 10.2337/db07-0360 · DOI · Paper page
- Seals, 2003, The ADAMs family of metalloproteases: multidomain proteins with multiple functions., Genes Dev, 17, 730, 10.1101/gad.1039703 · DOI · Paper page
- Xanthoulea, 2004, Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases., J Exp Med, 200, 367376, 10.1084/jem.20040435 · DOI · Paper page
- Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease., HEPATOLOGY, 41, 13131321, 10.1002/hep.20701 · DOI · Paper page
- Chen, 2009, TNFalpha, a potent lipid metabolism regulator., Cell Biochem Funct, 27, 407416, 10.1002/cbf.1596 · DOI · Paper page
- Feingold, 1987, Tumor necrosis factoralpha stimulates hepatic lipogenesis in the rat in vivo., J Clin Invest, 80, 184190, 10.1172/JCI113046 · DOI · Paper page
- Comhair, 2011, Dietary cholesterol, female gender and n3 fatty acid deficiency are more important factors in the development of nonalcoholic fatty liver disease than the saturation index of the fat., Nutr Metab (Lond), 8, 4, 10.1186/1743-7075-8-4 · DOI
- Wouters, 2008, Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis., HEPATOLOGY, 48, 474486, 10.1002/hep.22363 · DOI · Paper page
- Tilg, 2008, Insulin resistance, inflammation, and nonalcoholic fatty liver disease., Trends Endocrinol Metab, 19, 371379, 10.1016/j.tem.2008.08.005 · DOI · Paper page
- Fon, 2007, TNFalpha interferes with lipid homeostasis and activates acute and proatherogenic processes., Physiol Genomics, 31, 216227
- Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes., HEPATOLOGY, 48, 792798
- Bieghs, 2012, LDL Receptor knockout mice are a physiological model particularly vulnerable to study the onset of Inflammation in nonalcoholic fatty liver disease., PLoS ONE, 7, e30668, 10.1371/journal.pone.0030668 · DOI · Paper page
- Kaneko, 2011, Tumor necrosis factoralpha converting enzyme inactivation ameliorates highfat dietinduced insulin resistance and altered energy homeostasis., Circ J, 75, 24822490, 10.1253/circj.CJ-11-0182 · DOI
Cited by
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Self-citationInflammation: The Common Pathway of Stress-Related Diseases
Liu, Y.-Z., Wang, Y.-X., & Jiang, C.-L. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00316 · Cited by 800
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518
Turner, N., Kowalski, G. M., Leslie, S. J., Risis, S., Yang, C., Lee-Young, R. S., Babb, J. R., Meikle, P. J., Lancaster, G. I., Henstridge, D. C., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2913-1 · Cited by 430
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice
van der Heijden, R. A., Sheedfar, F., Morrison, M. C., Hommelberg, P. P., Kor, D., Kloosterhuis, N. J., Gruben, N., Youssef, S. A., de Bruin, A., Hofker, M. H., et al. (2015) · Aging · doi:10.18632/aging.100738 · Cited by 288
Self-citationApoptosis and non-alcoholic fatty liver diseases
Kanda, T., Matsuoka, S., Yamazaki, M., Shibata, T., Nirei, K., Takahashi, H., Kaneko, T., Fujisawa, M., Higuchi, T., Nakamura, H., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i25.2661 · Cited by 270
Metadata
- Authors
- Aparicio-Vergara, M., Hommelberg, P. P. H., Schreurs, M., Gruben, N., Stienstra, R., Shiri-Sverdlov, R., Kloosterhuis, N. J., de Bruin, A., van de Sluis, B., Koonen, D. P. Y., & Hofker, M. H.
- Venue
- Hepatology
- Published
- 2013-02
- Volume
- 57
- Issue
- 2
- Pages
- 566-576
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2134626804
- Cited by
- 40
- References
- 5
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 942 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.